| |
|
This ACT-HBV Web site is no longer available. Please visit www.hepb.org to find useful information about HBV. Thank you for your support. |
| |
 |
||
|
|
|
| Comparison of Entecavir to Adefovir in Chronic HBV Patients with Hepatic Decompensation | ||
|
|
|
|
Purpose: Compare safety and efficacy of entecavir and adefovir (Phase IIIb) Duration: Up to 96 weeks. Study started in July 2003. Trial sites are located throughout the United States. http://www.clinicaltrials.gov/ct/show/NCT00065507?order=1 |
|
Back to Trials |
|
|
|
||